Radiation therapy following mastectomy and chemotherapy for premenopausal women who have breast cancer that has spread to their lymph nodes is not only effective in terms of improving survival but cost effective as well, according to a Canadian study presented at the American Society for Therapeutic Radiology annual meeting in San Antonio.
More patients with large tumors confined to the prostate could benefit from hormone treatment plus radiation therapy -- particularly if hormones are given before, during and after radiation treatments, a researchers presented at the American Society for Therapeutic Radiology annual meeting in San Antonio.
A new long term study confirms that there is no difference between surgery and radiation therapy when treating patients who have prostate cancer. The study was presented at the American Society for Therapeutic Radiology annual meeting in San Antonio.
Breast cancer patients who choose lumpectomy and radiation therapy can feel confident in their decision. Patients who have breast conserving treatment have the same low risk of developing a second cancer as those who choose mastectomy, according to a new 15-year study presented at the American Society for Therapeutic Radiology annual meeting in San Antonio.
A new drug is proving to be effective in treating one of the most common side effects patients suffer during and after radiation treatments for head and neck cancer. The drug, amifostine, is easing xerostomia (severe dry mouth), a condition that can make it very difficult for these patients to eat, drink and even speak. The study was presented at the American Society for Therapeutic Radiology annual meeting October 31 - November 4, 1999 in San Antonio, TX.
Intensity modulated radiation therapy is a safe way to accurately deliver high doses of radiation to the prostate while preserving normal tissue nearby, a new study shows. The study was presented at the American Society for Therapeutic Radiology annual meeting October 31 - November 4, 1999 in San Antonio, TX.
Mixing neutrons and photons as the types of radiation used to treat cancer confined to the prostate results in a 90 percent three-year disease free survival rate, according to a new study presented at the American Society for Therapeutic Radiology annual meeting in San Antonio.
Prostate cancer patients who have disease locally confined to the prostate and who have PSA levels greater than ten before treatment dramatically benefit from higher doses of radiation, according to a new study presented at the American Society for Therapeutic Radiology annual meeting in San Antonio.
Lower doses of radiation, combined with a technique called stereotactic radiosurgery, can preserve hearing, avoid damage to facial nerves and successfully treat acoustic neuromas, according to a new study presented at the American Society for Therapeutic Radiology annual meeting in San Antonio.
Prostate cancer patients who smoke might want to quit. A survey of patients treated with radiation therapy for the disease found that none of those who smoked were potent six years after treatment compared to about two-thirds of patients who were non-smokers. The survey was presented at the American Society for Therapeutic Radiology annual meeting in San Antonio.
In what could be a major breakthrough in the treatment of patients with cardiovascular disease, radiation treatments are now being used to keep once-blocked arteries from re-blocking. The study was presented at the American Society for Therapeutic Radiology annual meeting in San Antonio.
Adding weekly chemotherapy to radiation therapy dramatically increases survival rates of some patients with advanced head and neck cancer, according to a new study presented at the American Society for Therapeutic Radiology annual in San Antonio.
Reducing the total time of radiation treatments without decreasing the total dose or increasing the total dose without changing the total treatment time led to an improvement over standard treatment for patients with locally advanced head and neck cancer, a study by the Radiation Therapy Oncology Group (RTOG) indicates. The study was presented at the American Society for Therapeutic Radiology annual meeting in San Antonio.
Newly developed techniques and procedures will be highlighted at the annual meeting of the American Society for Therapeutic Radiology and Oncology, which will be held October 31 - November 4 at the Henry B. Gonzalez Convention Center in San Antonio, TX.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right